First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer.

Thirty-one consecutive patients with advanced epithelial ovarian cancer entered a phase II study with cisplatin and etoposide combination chemotherapy. None of them had received prior chemotherapy or radiotherapy. Most patients had advanced (88%) or far advanced (61%) disease. All 31 patients are ev...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Athanassiou, A. E., Bafaloukos, D., Pectasides, D., Dimitriadis, M., Varthalitis, I., Barbounis, V.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1989
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2247295/
https://ncbi.nlm.nih.gov/pubmed/2803952
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items